S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Critical asset just had biggest fall on record (Ad)
The former chairman of the state-owned Bank of Beijing is being investigated for alleged corruption
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet

Lyell Immunopharma (LYEL) News Today

$3.07
+0.15 (+5.14%)
(As of 03/1/2024 ET)
SourceHeadline
MarketBeat logoLyell Immunopharma (NASDAQ:LYEL) Trading 7.9% Higher
americanbankingnews.com - March 3 at 5:42 AM
MarketBeat logoLyell Immunopharma (NASDAQ:LYEL) Price Target Cut to $6.00
americanbankingnews.com - March 2 at 2:42 AM
finance.yahoo.com logoLyell Immunopharma Inc (LYEL) Reports 2023 Financial Results and Business Highlights
finance.yahoo.com - February 28 at 7:41 PM
globenewswire.com logoLyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023
globenewswire.com - February 28 at 4:05 PM
globenewswire.com logoLyell Immunopharma Announces Participation in March Investor Conferences
globenewswire.com - February 26 at 4:05 PM
investing.com logoLyell Immunopharma Inc (LYEL)
investing.com - February 20 at 8:22 PM
benzinga.com logoLyell Immunopharma Stock (NASDAQ:LYEL) Dividends: History, Yield and Dates
benzinga.com - January 30 at 1:29 PM
finance.yahoo.com logoLyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 8:43 PM
health.usnews.com logoHeather D. Lyell
health.usnews.com - December 19 at 2:11 PM
finance.yahoo.com logoCompanies Like Lyell Immunopharma (NASDAQ:LYEL) Are In A Position To Invest In Growth
finance.yahoo.com - December 19 at 9:11 AM
seekingalpha.com logoLyell Immunopharma: Potential Solid Tumor Targeting With CAR-T And TIL
seekingalpha.com - November 10 at 4:53 PM
markets.businessinsider.com logoWhy Lyell Immunopharma Shares Are Rising Today
markets.businessinsider.com - November 10 at 11:52 AM
msn.com logoLyell gets FDA orphan drug designation for melanoma drug candidate
msn.com - November 9 at 10:43 PM
finance.yahoo.com logoLyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma
finance.yahoo.com - November 9 at 5:42 PM
msn.com logoLyell Immunopharma reports Q3 results
msn.com - November 8 at 9:01 PM
finance.yahoo.com logoLyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
finance.yahoo.com - November 7 at 5:45 PM
finance.yahoo.com logoLyell Immunopharma Presentations at SITC Highlight New Nonclinical Data on Product Candidates and Innovative Technology to Shorten TIL Manufacturing
finance.yahoo.com - October 31 at 9:55 AM
finance.yahoo.com logoLyell Immunopharma, Inc. (NASDAQ:LYEL) has caught the attention of institutional investors who hold a sizeable 49% stake
finance.yahoo.com - October 9 at 7:56 AM
finance.yahoo.com logoLyell Immunopharma Announces the Acceptance of Six Abstracts for Presentation at 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
finance.yahoo.com - September 27 at 3:04 PM
marketwatch.com logoLyell Immunopharma Shares Up 8% on Cellares Collaboration
marketwatch.com - September 11 at 3:22 PM
finance.yahoo.com logoCellares and Lyell to Evaluate Automated Manufacturing of Lyell's CAR T-Cell Therapy on Cellares' Cell Shuttle Platform
finance.yahoo.com - September 11 at 10:02 AM
marketbeat.com logoXTX Topco Ltd Has $676,000 Stake in Lyell Immunopharma, Inc. (NASDAQ:LYEL)
marketbeat.com - September 10 at 4:14 AM
finance.yahoo.com logoLyell Immunopharma to Participate in Upcoming Investor Conferences
finance.yahoo.com - August 31 at 7:26 PM
finance.yahoo.com logoAnalysts' Revenue Estimates For Lyell Immunopharma, Inc. (NASDAQ:LYEL) Are Surging Higher
finance.yahoo.com - August 29 at 7:56 AM
msn.com logoJP Morgan cuts Lyell to neutral, pending data for cell therapy platform
msn.com - August 28 at 9:48 PM
msn.com logoJP Morgan Downgrades Lyell Immunopharma (LYEL)
msn.com - August 28 at 4:48 PM
marketbeat.com logoBarclays PLC Has $579,000 Stock Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL)
marketbeat.com - August 27 at 4:03 AM
msn.com logoLyell Immunopharma: Once Huge IPO Now Waiting For Clinical Data
msn.com - August 26 at 6:29 PM
marketbeat.com logoMirae Asset Global Investments Co. Ltd. Reduces Stock Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL)
marketbeat.com - August 24 at 4:01 AM
markets.businessinsider.com logoH.C. Wainwright Reaffirms Their Buy Rating on Lyell Immunopharma (LYEL)
markets.businessinsider.com - August 9 at 8:38 PM
finance.yahoo.com logoLyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023
finance.yahoo.com - August 8 at 7:37 PM
lse.co.uk logoMaxCyte inks strategic platform license with Lyell Immunopharma
lse.co.uk - July 6 at 1:19 PM
finance.yahoo.com logoMaxCyte Signs Strategic Platform License with Lyell Immunopharma
finance.yahoo.com - July 6 at 8:18 AM
finance.yahoo.com logoLyell Immunopharma Appoints Matthew Lang as Chief Business Officer
finance.yahoo.com - July 5 at 7:51 PM
finance.yahoo.com logoWhy Shares of Lyell Immunopharma Jumped This Week
finance.yahoo.com - June 16 at 1:59 PM
finance.yahoo.com logoLyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
finance.yahoo.com - June 7 at 4:24 PM
marketbeat.com logoFirst Trust Advisors LP Buys 30,500 Shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL)
marketbeat.com - June 7 at 5:32 AM
finance.yahoo.com logoEven after rising 12% this past week, Lyell Immunopharma (NASDAQ:LYEL) shareholders are still down 31% over the past year
finance.yahoo.com - June 1 at 10:11 AM
marketbeat.com logoCitigroup Inc. Has $939,000 Stock Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL)
marketbeat.com - June 1 at 5:29 AM
msn.com logoHC Wainwright & Co. Reiterates Lyell Immunopharma (LYEL) Buy Recommendation
msn.com - May 5 at 12:28 PM
markets.businessinsider.com logoLyell Immunopharma (LYEL) Receives a Buy from H.C. Wainwright
markets.businessinsider.com - May 5 at 7:27 AM
finance.yahoo.com logoLyell Immunopharma (LYEL) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 4 at 11:56 PM
msn.com logoLyell Immunopharma reports Q1 results
msn.com - May 4 at 6:56 PM
finance.yahoo.com logoLyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2023
finance.yahoo.com - May 4 at 6:56 PM
finance.yahoo.com logoThere's No Escaping Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) Muted Revenues
finance.yahoo.com - April 17 at 9:02 AM
benzinga.com logoTORL BioTherapeutics Launches with $158 Million Series B Financing to Advance Development of Novel Oncology Biologics
benzinga.com - April 13 at 7:10 PM
marketbeat.com logoShort Interest in Lyell Immunopharma, Inc. (NASDAQ:LYEL) Increases By 14.2%
marketbeat.com - March 31 at 8:50 PM
finance.yahoo.com logoAurinia (AUPH) Surges 11.0%: Is This an Indication of Further Gains?
finance.yahoo.com - March 27 at 9:12 AM
finance.yahoo.com logoLyell Immunopharma, Inc. (NASDAQ:LYEL) has caught the attention of institutional investors who hold a sizeable 47% stake
finance.yahoo.com - March 26 at 2:32 PM
marketbeat.com logoLyell Immunopharma, Inc. (NASDAQ:LYEL) Short Interest Up 5.4% in February
marketbeat.com - March 16 at 1:40 AM
Get Lyell Immunopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LYEL and its competitors with MarketBeat's FREE daily newsletter.



LYEL Media Mentions By Week

LYEL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LYEL
News Sentiment

0.17

0.65

Average
Medical
News Sentiment

LYEL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LYEL Articles
This Week

9

1

LYEL Articles
Average Week

Get Lyell Immunopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LYEL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:LYEL) was last updated on 3/3/2024 by MarketBeat.com Staff